ANA-12
ANA-12[edit | edit source]
ANA-12 is a small molecule that acts as a selective antagonist of the tropomyosin receptor kinase B (TrkB), which is the high-affinity receptor for brain-derived neurotrophic factor (BDNF). ANA-12 is of interest in the field of neuroscience and pharmacology due to its potential therapeutic applications in neurological disorders and psychiatric disorders.
Mechanism of Action[edit | edit source]
ANA-12 functions by selectively inhibiting the activity of TrkB receptors. TrkB is a member of the neurotrophin receptor family and is primarily activated by BDNF. The binding of BDNF to TrkB initiates a cascade of intracellular signaling pathways that are crucial for neuronal survival, synaptic plasticity, and cognitive function. By antagonizing TrkB, ANA-12 can modulate these pathways, which may be beneficial in conditions where BDNF signaling is dysregulated.
Potential Therapeutic Applications[edit | edit source]
Research into ANA-12 has suggested several potential therapeutic applications:
- Depression: Dysregulation of BDNF and TrkB signaling has been implicated in the pathophysiology of depression. ANA-12, by modulating this pathway, may offer a novel approach to treating depression.
- Anxiety disorders: Similar to depression, anxiety disorders may involve altered BDNF signaling. ANA-12 could potentially be used to address these alterations.
- Neurodegenerative diseases: Conditions such as Alzheimer's disease and Parkinson's disease involve neurodegeneration where BDNF-TrkB signaling plays a protective role. Modulating this pathway with ANA-12 might offer neuroprotective benefits.
Research and Development[edit | edit source]
ANA-12 is primarily used in preclinical research settings. Studies have demonstrated its ability to cross the blood-brain barrier, making it a valuable tool for in vivo studies of TrkB function. Ongoing research is focused on understanding the full range of its effects and potential side effects in various models of disease.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
